|
|
|
|
|
Antidepressants in children: What do we know & what should we do?
|
 |
|
|
|
|
|
|
|
Hype in the news media following studies suggesting a possible increased risk of suicide among adolescents taking antidepressants has put psychiatrists, pediatricians, and other primary care doctors in a real bind. Parents are upset, confused, and afraid of the possible negative affects of medication, and many doctors are unsure about the strength of the scientific evidence, unnerved by the FDA's black box warning on antidepressants, and unsure about the agency's new monitoring guidelines.
"Antidepressants in Children: What do We Know and What Should We Do?," puts the existing research on this highly charged topic into clear perspective and provides practical guidance for physicians on managing depressed adolescents in light of safety concerns.
Authored and narrated by John Walkup, MD, Johns Hopkins associate professor of child and adolescent psychiatry, this balanced and thoughtful 40-minute presentation is a must-have resource for physicians wanting to clear up the confusion and cut through the hype surrounding antidepressant use in children.
Here's what you'll learn as you listen:
What the TADS and other key studies really say
An expert's perspective on safety and efficacy data
Potential variables affecting study results
Possible causes of increased suicidality in study populations
Data on the positive impact of SSRIs on suicide incidencev
How to counsel parents on antidepressant risks and benefits
Cognitive Behavorial Therapy and antidepressant use
Suggestions in patient education, monitoring and informed consent
Order today so you can clear the confusion and hype surrounding antidepressant usage in children – for your patients, their parents, and for yourself. Your purchase is RISK-FREE with our 100% guarantee of satisfaction!
ORDER TODAY!
|
|
|
